Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Clinical trial NCT00078312 · COMPLETED

Trial details

NCT number: NCT00078312
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Sleep Apnea, Obstructive Sleep Apnea Syndromes Shift-Work Sleep Disorder

Start date: 2004-01-01
Primary completion: 2006-07-01
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.